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Palauans are an isolated population in Micronesia with lifetime prevalence of schizophrenia (SCZD) of 2%, compared
to the world rate of ∼1%. The possible enrichment for SCZD genes, in conjunction with the potential for reduced
etiological heterogeneity and the opportunity to ascertain statistically powerful extended pedigrees, makes Palauans
a population of choice for the mapping of SCZD genes. We have used a Markov-chain Monte Carlo method to
perform a genomewide multipoint analysis in seven extended pedigrees from Palau. Robust multipoint parametric
and nonparametric linkage (NPL) analyses were performed under three nested diagnostic classifications—core, spec-
trum, and broad. We observed four regions of interest across the genome. Two of these regions—on chromosomes
2p13-14 (for which, under core diagnostic classification, and parametric ) and 13q12-22 (forNPLp 6.5 LODp 4.8
which, under broad diagnostic classification, parametric , and, under spectrum diagnostic classification,LODp 3.6
parametric )—had evidence for linkage with genomewide significance, after correction for multiple testing;LODp 3.5
with the current pedigree resource and genotyping, these regions are estimated to be 4.3 cM and 19.75 cM in size,
respectively. A third region, with intermediate evidence for linkage, was identified on chromosome 5q22-qter (for
which, under broad diagnostic classification, parametric ). The fourth region of interest had only borderlineLODp 2.5
suggestive evidence for linkage (on 3q24-28; for this region, under broad diagnostic classification, parametric
). All regions exhibited evidence for genetic heterogeneity. Our findings provide significant evidence forLODp 2.0
susceptibility loci on chromosomes 2p13-14 and 13q12-22 and support both a model of genetic heterogeneity and
the utility of a broader set of diagnostic classifications in the population from Palau.
Introduction
Schizophrenia (SCZD [MIM 181500]) is a severe and
debilitating psychiatric disorder that affects ∼1% of the
world’s population. Family, twin, and adoption studies
have indicated substantial heritability (Gottesman and
Shields 1982; Kendler and Diehl 1993). Segregation
patterns indicate that a single-gene theory is not viable
(Elston et al. 1978; O’Rourke et al. 1982; Tsuang et
al. 1982a; Risch and Baron 1984) and that, more likely,
several genes of modest effect exist (Suarez et al. 1994).
Reduced penetrance is evident on the basis of twin stud-
ies (Kendler 1983; Gottesman 1991), and phenocopies,
of both environmental (Davison 1983) and drug-re-
lated types (Tsuang et al. 1982b), have been docu-
mented. Furthermore, the lack of consensus of existing
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results from linkage analyses suggests that substantial
genetic heterogeneity may exist.
For mapping of genes for complex diseases, isolated
populations have been suggested as a resource of choice
(Wright et al. 1999). The expectation is of simplified
genetic etiology and, thus, of diminished genetic het-
erogeneity, making the complex disease easier to dissect.
Furthermore, for gene localization, extended pedigrees
may be more statistically powerful than smaller family
units, unless the disease genes are very frequent and have
low risk (Durner et al. 1999). However, for SCZD, few
extended pedigrees exist, primarily owing to the low
marriage and reproduction rates of individuals who suf-
fer from the disease (Bo¨o¨k et al. 1978).
The Republic of Palau, also known as “Belau,” is the
westernmost archipelago in Micronesia. Blood-group
clustering, linguistic analysis, and ethnographic studies
indicate that the Palauan population has developed in
relative isolation, even from other Micronesian popu-
lations, since the original settlement of Palau 2,000
years ago (Simmons et al. 1965). The basic unit of social
organization in Palau is the clan, a blood-based, land-
holding group of families that share a common female
founder; hence, extended pedigrees can be ascertained
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Table 1
Characteristics of the Seven Pedigrees in the Linkage Analysis
PEDIGREE
NO. OF INDIVIDUALS AFFECTEDa
Core Spectrum Broad Total
15831 10 (10) 10 (10) 13 (12) 57 (40)
15841 9 (8) 13 (12) 14 (13) 51 (29)
20241 6 (6) 6 (6) 6 (6) 15 (8)
22381 3 (3) 3 (3) 3 (3) 21 (14)
24401 5 (4) 5 (4) 5 (4) 31 (12)
26491 4 (4) 5 (5) 5 (5) 30 (14)
26492 5 (5) 5 (5) 5 (5) 24 (10)
Total 42 (40) 47 (45) 51 (48) 229 (127)
a Numbers in parentheses indicate the number of individuals for
whom genotyping data were available.
and studied. The lifetime prevalence of SCZD for in-
dividuals in Palau has been estimated, by complete as-
certainment, to be 2%, compared to the worldwide rate
of 0.8%–1% (Myles-Worsley 1999). For these reasons,
the Palauan extended pedigrees with SCZD may rep-
resent an extremely important resource for gene local-
ization, for SCZD.
In this study, we have chosen to analyze three nested
diagnostic classifications—core, spectrum, and broad
(see the “Psychiatric Assessment” subsection, below).
Core and spectrum diagnostic classifications are con-
sidered under the assumption of a continuum for which
common genetic mechanisms may exist (also see Wang
et al. 1995; Brzustowicz et al. 2000; Gurling et al.
2001). A broad classification, including affective psy-
chotic disorders, is a more controversial classification,
although one that has also been suggested elsewhere
(Straub et al. 1995; Kendler et al. 1996). It has been
shown that SCZD and bipolar disorder do not signifi-
cantly coaggregate (Baron et al. 1982; Maier et al.
1993). However, there still remains evidence for over-
lap; for example, families containing both individuals
with SCZD and individuals with bipolar disorder are
at increased risk for schizoaffective disorder, and several
similarities, both clinical and epidemiological, exist be-
tween the two disorders. There is increasing evidence
for shared chromosomal regions (Berrettini 2000; Baron
2001), and, for such loci, a broad classification has in-
creased power for linkage detection (Kendler et al.
1996). Our approach, to consider analysis under all
three classifications, allows for a more comprehensive
set of hypotheses to be tested.
A two-point analysis has previously been performed
using the core diagnostic phenotype in a single large ped-
igree from Palau (Coon et al. 1998). A single suggestive
region on chromosome 2p13-14 was indicated. Multi-
point analyses were not possible at that time (owing to
lack of appropriate software) and hence were not per-
formed. In the analyses presented in the present study, a
genome search with seven extended pedigrees from
Palau—including the same single large pedigree (15831)
that was examined previously, analyzed under a more
comprehensive set of diagnostic classifications—was per-
formed. We performed multipoint analyses across the
genome (22 autosomes) by Markov-chain Monte Carlo
methodology and calculated both model-based and non-
parametric statistics. The larger resource size that we con-
sidered, in addition to the more sophisticated analyses
that we performed, results in a substantially more pow-
erful study.
Subjects and Methods
Psychiatric Assessment
After informed consent was obtained, subjects were
interviewed by a board-certified psychiatrist (Dr. Wil-
liam Byerley), by a modified version of the semistruc-
tured interview called “the Schedule for Affective Dis-
orders and Schizophrenia—Lifetime Version” (Endicott
and Spitzer 1978). All interviews were conducted in the
presence of a Belau National Hospital behavioral-health
professional, and, when subjects preferred to be inter-
viewed in their native language, the necessary translation
was performed. Medical records of any individual who
received hospital inpatient or outpatient psychiatric care
were obtained. All available information was rendered
anonymous and was reviewed separately and blind to
genotypic data, by two board-certified psychiatrists (Drs.
Fred Reimherr and Paul W. Wender). Research Diag-
nostic Criteria (Spitzer et al. 1978) were used to arrive
at a consensual diagnosis. For any diagnostic disagree-
ments, further information was requested. For diagnos-
tic disparity that could not be resolved, the individual
was coded as unknown.
Three nested diagnostic classifications were used in
this study—core, spectrum, and broad. The core diag-
nostic classification was the narrowest definition for af-
fected status and included diagnoses of chronic SCZD
(symptoms 12 years duration), subchronic SCZD (symp-
toms 11 year but !2 years duration), and schizoaffective
disorder (mainly schizophrenic course). The spectrum
diagnostic classification included those classified as af-
fected under the core definition, with, in addition, the
nonaffective psychotic diagnoses of acute SCZD (symp-
toms !6 mo duration) and subacute SCZD (symptoms
16 mo but !1 year duration). In our sample, there were
no schizotypal diagnoses, which would otherwise also
fit in this classification. The broad diagnostic classifi-
cation was the most inclusive and included all psychotic
disorders, including the affective psychotic diagnoses of
schizoaffective disorder (mainly affective course), bi-
polar disorder with psychotic symptoms, and psychotic
depression.
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Pedigree Sample
Medical records at Belau National Hospital were used
to identify individuals who met diagnostic criteria for
entry in the study. Consenting individuals were inter-
viewed for family history and genealogical information,
to ascertain other potentially affected individuals and to
reveal genealogical ties to other previously ascertained
pedigrees. The initial framework for the pedigree ascer-
tainment was provided by Dr. Anthony Polloi. Since Pa-
lau is an island nation with a finite population, many
complex marriage connections exist within and between
the seven defined pedigrees. For these analyses, the ped-
igrees were constructed blind to genotypic data and with
clusters of affected individuals grouped under common
founders. There were no duplications of individuals in
multiple pedigrees. Seven extended pedigrees from Palau
that had comparable genotyping data were considered
in this study. Each pedigree contained 3–10 genotyped
individuals coded as affected under the core diagnostic
classification (see the “Psychiatric Assessment” subsec-
tion and table 1). The pedigrees comprised 15–57 in-
dividuals (8–40 individuals with genotypic data) and
4–6 generations. Table 1 summarizes the number of in-
dividuals coded as affected under the core, spectrum,
and broad diagnostic classifications, in the seven pedi-
grees. Additional individuals were genotyped (up to 3,
5, and 8 affected individuals for the core, spectrum, and
broad diagnostic classifications, respectively) for a chro-
mosome 2 region where previous interesting two-point
evidence had been found in a single pedigree (Coon et
al. 1998, pedigree 15831).
The average of coefficient of kinship (w) between af-
fected pairs was used to measure the level of clustering
of the affected individuals in each pedigree. On aver-
age, across all seven pedigrees, w was found to range
from .05 to .06, depending on the diagnostic classifi-
cation used. The w value indicates the probability that
a gene picked at random from two individuals is iden-
tical by descent (IBD); for example, for sibs,wp 1/4
for uncle-nephew pairs, for secondwp 1/8 wp 1/64
cousins, and for two individuals with no bloodwp 0
relation. The value (or ) indicates that,wp .05 wp .06
on average, the relatedness of affecteds within pedi-
grees is approximately the same as that of first cousins.
This lack of dense clustering, although not unexpected,
indicated that maintaining the full-pedigree structures
for analysis would maximize the power of the resource
(see the “Linkage Analysis” subsection, below).
Genotyping
Blood samples were obtained from consenting indi-
viduals, and high-molecular-weight DNA was extracted
by standard techniques (Bell et al. 1981). A set of 391
di-, tri-, and tetranucleotide repeat markers from The
Cooperative Human Linkage Center (Murray et al.
1994) screening set 6.0 were used to screen the genome
(autosomes only). In addition, supplemental markers
were genotyped, to cover telomeric regions thought to
be gene rich (Saccone et al. 1992). The marker map was
generated primarily on the basis of data from the Marsh-
field marker database (Center for Medical Genetics,
Marshfield Medical Research Foundation) but also on
the basis of data from The Cooperative Human Linkage
Center and from the Genome Database (see the “Elec-
tronic-Database Information” section). Genotyping was
performed by standard techniques (details in Coon et al.
1994). The average resolution for the genomic screen
markers was 7–8 cM. For the region of interest on chro-
mosome 2, additional markers were genotyped, and the
resolution for this chromosome was higher (on average,
1 cM). Inconsistencies and incompatibilities were de-
tected by a modified version of the UNKNOWN pro-
gram from the LINKAGE analysis software suite (La-
throp et al. 1984). In addition, in candidate regions,
improbable double recombinants were identified by
comparison of observed and expected recombination
rates. Clearly erroneous genotypes were deleted, and, in
cases in which the discrepancy was not clearly apparent
and the problem could not be resolved, genotypic data
for the problematic marker were deleted for all individ-
uals in the pedigree. Marker-allele frequencies were
found to vary widely between the Palauan population
and populations of northern-European descent. All
marker-allele frequencies and haplotype frequencies used
in the analyses were calculated on the basis of the ped-
igree sample.
Linkage Analysis
Estimation of multipoint IBD vectors.—The lack of
dense clustering of affecteds in the pedigrees suggested
that a methodology that allowed analysis of the pedi-
grees in their full structure would be advantageous, since
extensive amounts of information on segregation and on
sharing are lost when the pedigrees are split. In addition,
multipoint analysis was considered essential—since
marker heterozygosity was generally lower in the Pa-
lauan population compared to northern Europeans and
since multipoint analysis would greatly reduce the effect
of this poorer heterozygosity. The size and structure of
the pedigrees prohibited the use of more-standard soft-
ware—such as the GENEHUNTER suite (Kruglyak et
al. 1996)—to calculate the multipoint inheritance vec-
tors (haplotype frequencies) necessary to calculate mul-
tipoint linkage statistics. We have used the Markov-
chain Monte Carlo method MCLINK (Thomas et al.
2000), which provides haplotype reconstructions by
blocked Gibbs sampling (Jensen et al. 1995). In the Mar-
kov chain, these haplotype reconstructions appear in
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Table 2
Genetic Models Used in the Model-Based Linkage Analyses
DIAGNOSTIC
CLASSIFICATION
DOMINANT GENE RECESSIVE GENE
Frequency
P Valuea
Frequency
P Valuea
P(AA) P(AB) P(BB) P(AA) P(AB) P(BB)
Core:
Male .00492 .0006 .55 .55 .09909 .0006 .0006 .55
Female .0006 .275 .275 .0006 .0006 .275
Spectrum:
Male .01613 .0062 .75 .75 .178885 .0062 .0062 .75
Female .0062 .375 .375 .0062 .0062 .375
Broad:
Male .0178 .0104 .85 .85 .1882 .0104 .0104 .85
Female .0104 .425 .425 .0104 .0104 .425
a The wild-type allele is represented by “A,” and the disease allele is represented by “B.”
proportion to their true frequencies, and, hence, by sam-
pling from the chain, a Monte Carlo estimate for the
linkage statistics can be found.
Linkage statistics.—Multipoint LOD score and non-
parametric linkage (NPL) analyses were performed. The
TLOD statistic (Abkevich et al., in press) was used for
the model-based LOD-score analysis. This statistic was
first introduced by Go¨ring and Terwilliger (2000). It is
a combination of multipoint and two-point procedures,
exploiting the advantages and discarding the disadvan-
tages of both. Multipoint inheritance information is cal-
culated. This is then used to determine the IBD proba-
bilities for a specific marker, and the LOD score is
calculated under a two-point paradigm. The use of mul-
tipoint data to determine the IBD vector for a specific
marker reduces false-positive results, to which standard
two-point analyses are prone, by better distinguishing
between alleles that are IBD and those that are identical
by state. The calculation of the TLOD statistic under
the two-point paradigm allows the inclusion of the re-
combination fraction (v) as a parameter, and, hence, the
statistic is as robust to model misspecification as a stan-
dard two-point statistic. Go¨ring and Terwilliger (2000,
pp. 1097–1098) describe v as “complex-valued,” indi-
cating both “the true probability of recombination” and
“modeling errors.” In other words, modeling errors can
be accounted for by the inclusion of this parameter. In
contrast, standard multipoint linkage analysis does not
include v as a free parameter (it is fixed at 0) and tends
not to be robust to errors in the specified model (Risch
and Giuffra 1992). As in standard two-point analyses,
HOMOG (Ott 1986) was used to calculate heteroge-
neity TLOD (het-TLOD) values.
For the nonparametric analyses, a slightly different
variation on the NPL as described by Kruglyak et al.
(1996) was used (for full details, see Camp et al., in
press). For ease of comparison between the het-TLOD
scores and NPL scores, we transformed each “raw NPL”
score 10 to an NPL score that could be interpreted on
a het-TLOD scale. This transformation was achieved by
mapping the empirical P value for the raw NPL score,
calculated from simulations under the null hypothesis of
no linkage, onto the distribution for het-TLOD scores
calculated under the same null simulations. The het-
TLOD score that corresponded to the empirical P value
for the raw NPL was considered to be the NPL score,
and these are the values that are reported throughout
this study.
Genetic models.—For the model-based analyses, ge-
netic models based on those derived by Kendler et al.
(1996) were used. In their study, Kendler et al. describe
models for three diagnostic definitions—narrow, inter-
mediate, and broad—which correspond to the classifi-
cations used herein—core, spectrum, and broad, re-
spectively. Lifetime risks under the three definitions were
assumed to be 0.6%, 3.0%, and 4.0%, and gene fre-
quencies were assigned for phenocopy rates of 10%,
20%, and 25%, for definitions of core (i.e., narrow),
spectrum (i.e., intermediate), and broad, respectively. In
Palau, a 2:1 male:female ratio was observed among all
known individuals with SCZD (Myles-Worsley et al.
1999); hence, the penetrance for female gene carriers
was set to half that for the males. The genetic models
used in the model-based analyses are shown in table 2.
The parameters in these models will not necessarily rep-
resent the true values for our population, particularly
because a single-gene model itself is not viable for SCZD.
However, several researchers (e.g., Clerget-Darpoux et
al. [1986], Risch et al. [1989], Vieland et al. [1993], and
Greenberg et al. [1998]) have shown that parametric
analysis, under a single-gene model and with arbitrary
genetic parameters, is a powerful method for detection
linkage evidence, provided that both dominant and re-
cessive models are considered. Hence, we adopted the
previously established models described above, for use
in our parametric analyses.
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Figure 1 Multipoint parametric and nonparametric linkage scores across the genome (22 autosomes in chromosomal order) for core (a),
spectrum (b), and broad (c) diagnostic classifications.
Multiple testing.—The guidelines suggested by Lander
and Kruglyak (1995) for the reporting of linkage find-
ings from a single genomewide scan have been widely
adopted; a genome with infinitely dense markers is con-
sidered in their calculations, to allow for the addition
of hint markers without inflation of type I errors. How-
ever, these guidelines fail to address the issue of multiple
testing, which arises from the analysis of multiple models
and phenotype classifications. Here, we have analyzed
six phenotype/model combinations—three nested diag-
nostic classifications for two genetic models (dominant
and recessive). To address our multiple-testing problem,
we have calculated the number (N) of effectively inde-
pendent analyses of these six models, by considering the
linear relationship between the analysis results (Camp
and Farnham, in press). This value is used in conjunction
with the theoretical rationale provided by Lander and
Kruglyak (1995) to calculate thresholds for significant,
intermediate, and suggestive evidence for linkage, which
account for the multiple testing. For this study, Np
, and the thresholds for significant, intermediate, and1.7
suggestive were found to be 3.5, 2.4, and 2.1, repre-
senting false-positive rates, per genome, of .05, .5, and
1, respectively.
Results
Figure 1 illustrates the multipoint-linkage results for the
three diagnostic classifications—core, spectrum,andbroad.
For each classification, three linkage statistics were calcu-
lated—dominant and recessive parametric het-TLOD
scores and an NPL score. Four regions of interest were
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Table 3
Maximum het-TLOD and NPL Scores for Regions on Chromosomes 2, 3, 5, and 13
DIAGNOSTIC
CLASSIFICATION
CHROMOSOME 2a CHROMOSOME 3b CHROMOSOME 5b CHROMOSOME 13a
het-TLODc NPL het-TLODc NPL het-TLODd NPL het-TLODc NPL
Core 4.8 R 6.5 1.3 R .5 1.0 D 1.1 2.5 R 1.4
Spectrum 4.4 R 4.5 1.3 R .5 1.7 D 1.0 3.5 R 1.3
Broad 3.6 R 3.4 2.0 R .5 2.5 D .9 3.6 R 1.1
a Best score across the region defined by markers 12.1 surrounding the peak, under the classification/best model combination.
b Best score across the region defined by markers 11.5 surrounding the peak, under the classification/best model combination.
c R p recessive.
d D p dominant.
identified, on chromosomes 2, 3, 5, and 13. Table 3 shows
a summary of the maximum het-TLOD and NPL scores
found for each of these regions.
A genomewide significant result was found on chro-
mosome 2p13-14, under the core diagnostic classifica-
tion. The maximum NPL score of 6.5 and the maximum
het-TLOD (4.8 under a recessive mode of inheritance)
were observed at marker D2S358, ∼85 cM from the p-
terminus. For both statistics, the score in the region was
above the suggestive threshold (i.e., 2.1) from D2S378
to D2S1394 (∼14 cM) and above 1.0 from D2S2240
to D2S410 (∼56 cM). For marker D2S358, v was es-
timated to be .02, and the proportion of families linked
(a) was estimated to be 1.0, suggesting homogeneity.
The value for v remained low throughout the region
(maximum ), with some evidence for hetero-vp .05
geneity apparent for markers toward the p-terminal end
of the region (minimum ). For further localiza-ap .6
tion, we calculated standard multipoint by-pedigree
LOD scores (v fixed at 0). Table 4 shows the maximum
by-pedigree recessive multipoint LOD scores across the
region of interest on chromosome 2p13-14, under the
core diagnostic classification. Dominant scores are also
shown, because the dominant resourcewide het-TLOD
score was borderline significant ( ).het-TLODp 3.4
However, since the recessive model performs better on
the whole, we have concentrated on this model. We have
chosen a by-pedigree threshold of 0.6, to signify prob-
able linkage to the region, since a multipoint LOD score
of 0.6 corresponds to a pointwise (uncorrected) P value
of .05. It can be seen that five of the seven pedigrees
score 0.6 under the recessive model, indicating that
some genetic heterogeneity for this locus may exist. Fig-
ure 2 shows the recessive multipoint LOD traces for the
five linked pedigrees. These traces may be used to es-
timate boundaries that delimit the region of interest. A
large (10.5) decrease in LOD score and a sharp change
in gradient is indicative of an informative recombinant
event in a pedigree. The base denotes the most outward
point of the recombination event. A more gradual
change in gradient indicates that the markers (or the
string of markers) between which the recombinant event
takes place are not fully informative. In this latter case,
the addition of more markers could lead to better def-
inition of the region. By this method, pedigrees 15831,
26492, and 22381 define recombinant boundaries en-
compassing a 4.3-cM region. Pedigree 15831 defines the
q-boundary (toward the q-terminus) as being at 85.19
cM, and pedigrees 26492 and 22381 define the p-
boundaries (toward the p-terminus) as being at 80.82
and 80.92 cM, respectively. The markers delimiting
these inferred recombinant events are D2S136/D2S134
and D2S327.
A second significant genomewide result was found
for a region on chromosome 13q12-22, under a reces-
sive mode of inheritance, for both the broad and spec-
trum diagnostic classifications. The maximum score was
a recessive het-TLOD score of 3.6, under the broad
classification, at marker D13S894, ∼24 cM from the p-
terminus. An almost equivalent score was found for the
same marker under the spectrum diagnostic classifica-
tion (recessive ). The recessive scorehet-TLODp 3.5
was above the suggestive threshold between markers
D13S1493 and D13S325 (∼13 cM) and was above 1.0
between markers D13S1493 and D13S317 (∼38 cM).
The NPL scores in the region were much lower (1.1 and
1.3, under broad and spectrum diagnostic classifica-
tions, respectively) and were not significant. For both
classifications, the estimates for v and a were 0 and 1,
respectively, at the peak marker; however, some evi-
dence for heterogeneity was found to exist toward the
p-terminal end of the region ( ). Table 4 showsap .86
the maximum by-pedigree recessive multipoint LOD
scores across the region of interest on chromosome
13q12-22, under both the broad and spectrum diag-
nostic classifications. We focused on the broad classi-
fication since it performed marginally better; however,
conclusions were equivalent under the spectrum clas-
sification. For this region, four of the seven pedigrees
scored 0.6, indicating genetic heterogeneity, which
was not apparent from the het-TLOD analysis. In figure
3, the recessive multipoint LOD traces for the four
linked pedigrees under the broad diagnostic classifica-
tion are shown. There were no sharp changes in gra-
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Table 4
Maximum Parametric By-Pedigree Multipoint LOD Scores Calculated under the Classification/Best Model Combination for Each Region
Chromosome 2 Chromosome 3 Chromosome 5 Chromosome 13
Region D2S378–D2S1394 D3S2398–qter D5S2008–qter D13S1493–D13S325
Diagnostic classification/best model Core/Recessive (Dominantb) Broad/Recessive Broad/Dominant Broad (Spectrumc)/Recessive
Pedigree:a
15831 2.4 (2.8)d .7 3.5 .2 (.1)
15841 .2 (3.0) .7 1.6 1.1 (.7)
20241 1.2 (.3) .3 1.5 .9 (.8)
22381 .6 (1.1) .3 1.2 .6 (.8)
24401 1.5 (.7) .1 0 .4 (.4)
26491 .4 (.6) .5 .5 .1 (.2)
26492 .6 (.4) .4 0 1.1 (1.1)
a Standard multipoint LOD scores were calculated for each pedigree (v fixed at 0).
b For chromosome 2, scores for both recessive and dominant are given, since resource-wide genomewide significance and borderline significance
were found for the recessive and dominant models, respectively.
c For chromosome 13, recessive scores are given for the broad and the spectrum classification, since both gave resource-wide genomewide
significant results.
d Numbers in boldface italic indicate a score of at least .6, which we have taken as indication of linkage to the specific region.
dient. The estimated p- and q-boundaries for this region
were both gradual gradient changes and were both from
recombinants in pedigree 15841. The p-boundary was
found at 17.03 cM, and the q-boundary was found at
36.78 cM, defining a 19.75-cM region between markers
D13S1493 and D13S788. The gradual gradient changes
for these estimated boundaries indicate that the exact
positions of the recombinants are not well identified.
The addition of informative and highly polymorphic
markers around the boundary regions could allow bet-
ter determination of the location of these boundary-
defining recombinant events.
A region on chromosome 5q22-qter, with genome-
wide intermediate evidence for linkage, was found un-
der a dominant model for the broad diagnostic classi-
fication (dominant ; ; ).het-TLODp 2.5 vp 0 ap .2
The identified region (defined by a dominant het-TLOD
score of 1.0) lies between marker D5S2008 at 190
cM to the most telomeric marker, a distance of ∼15 cM.
Table 4 shows the maximum by-pedigree dominant
multipoint LOD scores across the region. These results
are concordant with the resourcewide dominant het-
TLOD results and suggest that much heterogeneity ex-
ists for this region. In fact, this intermediate hint seems
to be pedigree specific (for pedigree 15831, by-pedigree
multipoint ).LODp 3.5
A borderline genomewide suggestive region on chro-
mosome 3q24-28 was identified, under a recessive
model and the broad diagnostic classification (recessive
; ; ). The score remainedhet-TLODp 2.0 vp 0 ap 1
1.0 from marker D3S2398 at 204 cM to the most
telomeric marker, ∼16 cM. Table 4 shows that, although
all by-pedigree scores were positive, most linkage signals
were weak, and the scores for only two pedigrees were
at or above the by-pedigree threshold of 0.6 (pedigrees
15831 and 15841, which both scored 0.7).
Discussion
Our results suggest that the chromosomal regions of
2p13-14 and 13q12-22 contain genes involved in sus-
ceptibility to SCZD in Palau. Our analyses indicated that
the locus on 2p13-14 is within a 4.3-cM region. Fur-
thermore, the region could potentially be narrowed, by
use of markers alone, to 0.8 cM. The strength of the
linkage evidence (under core diagnostic classification,
and ), in addition to theNPLp 6.5 het-TLODp 4.8
small size of the region, makes the 2p13-14 region a
strong candidate for gene isolation via positional clon-
ing. There are several candidate genes in this region,
including ASCT1, a neutral amino acid transporter,
which was previously screened in some affecteds in ped-
igree 15831, with only polymorphisms not segregating
with the disease found (Bennett et al. 2000). Two studies
(DeLisi 1997; Faraone et al. 1998) have found nominal
evidence in this region, although most studies have not
found evidence here. Hence, the locus on 2p13-14 may
be of smaller effect in other populations.
The second locus, on chromosome 13q12-22, was
narrowed to a 19.75-cM region. By the addition of
markers alone, this region has the potential to be re-
duced to ∼6 cM in size. Hence, for this region, further
Palauan pedigrees or an alternative pedigree resource
will have to be utilized to progress to gene isolation.
Other studies have identified evidence for linkage to
13q, although these have generally found it at points
more distal than our defined region. Blouin et al. (1998)
reported significant linkage at 13q32, and this was con-
firmed by Brzustowicz et al. (1999); in addition, Lin et
al. (1995, 1997) and Shaw et al. (1998) have found
linkage evidence for this more distal region, although
others (e.g., Levinson et al. [2000]) have not. Further-
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Figure 2 Recessive multipoint LOD traces for the five pedigrees with linkage to the region on chromosome 2
more, evidence for linkage to bipolar disorder has been
found in this region (Kelsoe et al. 2001).
Two other regions in the genome, with lower evidence
for linkage, were found, on chromosomes 5q22-qter
and 3q24-28. There have been several reports of linkage
to the 5q22-qter region, in different populations. The
first report of linkage was in a set of Irish families
(Straub et al. 1997), followed by confirmation in 13
British families (Gurling et al. 2001). Linkage has also
been reported in Finnish families (Paunio et al. 2000)
and German families (Schwab et al. 1997). In addition,
Edenberg et al. (1997) found, in this region, evidence
for linkage to bipolar disorder. In our analyses, the sig-
nal at 5q22-qter was the consequence of a single ped-
igree (pedigree 15831) with a multipoint LOD score of
3.5. However, the consistent evidence for linkage in the
same region in other populations makes this region one
of interest and worthy of further investigation. The re-
gion on chromosome 3q24-28 is our lowest hint region
and has poor by-pedigree support. For SCZD pheno-
types, it has not been identified by other groups, al-
though Kelsoe et al. (2001) found evidence for linkage
to bipolar disorder. This region is of only tentative in-
terest, on the basis of our current results.
Full-chromosome multipoint analyses were performed
in this study, which are advantageous for several reasons.
Multipoint linkage analyses are more robust to false pos-
itives, which are associated with two-point analyses, and
hence are more reliable. In addition, a positive result
implies a segregating haplotype, rather than a single
marker; hence, a positive result implies flanking support
for the region. Furthermore, it increases the informa-
tiveness of the markers used in the analysis. This in-
creased informativeness proved important in our current
analyses, since several genomic-search markers were not
as polymorphic in Palauans as in other populations. This,
in addition to the ability to analyze the full-pedigree struc-
tures by Markov-chain Monte Carlo methods, enabled
us to more fully exploit the power of the resource. Here,
the utility of haplotype information in linkage analysis
was illustrated by the region on chromosome 5q22-qter.
This region was not previously identified in the two-point
analyses performed on pedigree 15831 (Coon et al.
1998). In the present study, pedigree 15831 scored 12.0,
both by TLOD and standard multipoint LOD analysis,
under a core diagnostic classification and dominant
model, as used by Coon et al. (1998). A similar obser-
vation was made recently by Garner et al. (2001), who
identified a new region of interest for severe bipolar dis-
order, by utilizing Markov-chain Monte Carlo techniques
to perform multipoint analyses in a single complex
pedigree.
Three nested diagnostic classifications were used in
the analyses presented here. For each classification, a
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Figure 3 Recessive multipoint LOD traces for the four pedigrees with linkage to the region on chromosome 13
different genetic model was implemented for the para-
metric analyses. The incremental changes in the number
of individuals considered as affected under these three
classifications was small (table 1). However, for some
loci, large differences in linkage evidence, between clas-
sifications, were found. Caution must be exercised when
conclusions are drawn on the basis of analyses per-
formed both under dynamic parametric genetic models
and under diagnostic classifications, since any conclu-
sions regarding diagnostic classification and changes in
genetic parameters are confounded. To attempt to dis-
tinguish between the effect of diagnostic classification
and changes in genetic parameters, we examined both
the by-pedigree parametric and the by-pedigree non-
parametric results, the latter of which was not influ-
enced by change in model parameters. For chromosome
2p13-14, the difference in linkage evidence observed,
between core and spectrum, was due to the performance
of unlinked pedigrees under the spectrum genetic model,
with sharing (assessed nonparametrically) in linked ped-
igrees unchanged between the two classifications. How-
ever, there was evidence for reduced sharing in pedigree
15831 under the broad classification. This indicates that
chromosome 2p13-14 could be influential in spectrum
diagnoses, in addition to core diagnoses, but that it is
not associated with affective psychoses. For chromo-
some 13q12-22, there was evidence for increased shar-
ing in pedigree 15841 under the spectrum diagnostic
classification versus the core diagnostic classification,
but there was no additional sharing evident under the
broad classification. All other pedigrees are consistent
in sharing, over the three classifications, as would be
expected (table 1). These results would suggest that the
locus on 13q12-22 is a susceptibility locus for spectrum
SCZD and that evidence of linkage to the broad phe-
notype may be due to a genetic model that better fitted
the data, rather than to the additional sharing of indi-
viduals that was evident under the broad classification.
For the single-pedigree region on chromosome 5q22-qter,
both the broad classification and the change in model
parameters influenced the linkage evidence, suggesting
that this locus may also predispose to affective psychoses.
Finally, for the region on chromosome 3q24-28, there
was evidence that sharing increased under the spectrum
diagnostic classification versus the core diagnostic clas-
sification and further increased under the broad classi-
fication, suggesting that this locus may also be involved
in a more extensive set of psychiatric diagnoses.
Our results suggest that use of a range of parametric
models and of phenotypes may be advantageous for
gene localization. The cost:benefit ratio for multiple
testing must, of course, be considered, since a correction
for the multiple analyses performed must be made.
However, the phenotypes are likely to be related, as are
the genetic models considered, and the correction may
be acceptable compared to the potential advantage of
increased power to detect linkage. In this study, the
phenotypes and genetic parameters were both nested.
In addition, the incremental changes across the three
diagnostic classifications were small. This led to a set
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of highly correlated analyses ( ) and a relativelyNp 1.7
modest multiple-testing correction (linkage thresholds
in LOD scores were raised by 0.2).
It is clear that SCZD is a disease with complex in-
heritance and with challenges both genetic and phe-
notypic. Our results support the use of a comprehensive
set of diagnostic classifications for linkage analysis, the
utility of haplotype information, and the use both of
robust parametric linkage statistics (Go¨ring and Ter-
williger 2000; Abkevich et al., in press) and of nonpara-
metric linkage statistics. Our findings provide significant
evidence for susceptibility loci on chromosomes 2p13-
14 and 13q12-22 and support a model of genetic het-
erogeneity. Furthermore, our findings suggest that loci
identified in a Palauan population may be both distinct
and shared with those in other populations.
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